loratadine; pseudoephedrine sulfate · Bayer Healthcare Llc · NDA 020470
Claritin-D 24 Hour
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220448, Dr Reddys · 020470-002Approved 6 Aug 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 220432, Dr Reddys · 020470-002Approved 16 Oct 2026Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020470 · 002 · RLD | tablet, extended release, oral | 10MG;240MG | open |